Pain Medicine, Interventional Pain Medicine · Baton Rouge, LA
NPI
1679717136
Since 2009
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
8080 Bluebonnet Blvd Ste 1000
Baton Rouge, LA, 70810
Phone (225) 924-2424
Groups this clinician bills Medicare through
Medicare paid, 2024
$192K
4,358 services
Medicare patients, 2024
487
Average age 74
Drug cost, 2024
$530K
8,681 prescriptions
Company payments, 2025
$1,169
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kelly E Boussert was code J1010 (injection, methylprednisolone acetate, 1 mg), 1,420 times for 36 patients. In total Kelly E Boussert billed 4,358 services in 44 codes, and Medicare paid $192K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,420 | 36 | $0.10 | $143 |
| 99213 Office E&M - Established | Office | 734 | 321 | $61.97 | $45K |
| 99214 Office E&M - Established | Office | 395 | 251 | $84.77 | $33K |
| 80305 Drug Tests | Office | 283 | 226 | $12.27 | $3,474 |
| 62323 Nerve Block Injection - Back | Facility | 124 | 99 | $69.05 | $8,562 |
| 64493 Nerve Block Injection - Back | Facility | 120 | 77 | $90.08 | $11K |
| 64494 Nerve Block Injection - Back | Facility | 115 | 75 | $51.52 | $5,925 |
| 64635 Destruction by Neurolytic Agent - Back | Facility | 104 | 66 | $143.01 | $15K |
| 64636 Destruction by Neurolytic Agent - Back | Facility | 103 | 66 | $43.86 | $4,518 |
| 64483 Nerve Block Injection - Back | Facility | 98 | 85 | $91.47 | $8,964 |
| 99212 Office E&M - Established | Office | 92 | 68 | $40.95 | $3,767 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 89 | 21 | $0.46 | $40.99 |
| 99203 Office E&M - New | Office | 84 | 84 | $78.52 | $6,596 |
| 72148 MRI/MRA - Spine | Office | 66 | 66 | $82.64 | $5,454 |
| 99204 Office E&M - New | Office | 55 | 55 | $115.56 | $6,356 |
By year: 2022 $155K for 2,581 services; 2023 $173K for 2,725 services; 2024 $192K for 4,358 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 283 | 226 | $12.27 | $3,474 |
Medicare prescription drug claims, 2024
In 2024, the drug Kelly E Boussert prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 1,893 prescriptions and refills. In total Kelly E Boussert wrote 8,681 Medicare prescriptions that cost $530K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,893 | 1,895 | 317 | $34K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 959 | 959 | 160 | $21K |
| Gabapentin Generic | 876 | 1,158 | 210 | $12K |
| Tramadol Hcl Generic | 854 | 855 | 209 | $5,757 |
| Tramadol Hcl Er Tramadol Hcl | 550 | 550 | 91 | $38K |
| Pregabalin Generic | 453 | 515 | 111 | $7,685 |
| Tizanidine Hcl Generic | 412 | 509 | 111 | $3,228 |
| Methocarbamol Generic | 253 | 306 | 98 | $2,101 |
| Cyclobenzaprine Hcl Generic | 234 | 269 | 65 | $1,447 |
| Belbuca Buprenorphine Hcl | 233 | 233 | 54 | $177K |
| Meloxicam Generic | 180 | 233 | 51 | $900 |
| Morphine Sulfate Er Morphine Sulfate | 163 | 163 | 19 | $4,034 |
| Oxycodone Hcl Generic | 141 | 141 | 21 | $1,710 |
| Diclofenac Sodium Generic | 138 | 186 | 37 | $2,089 |
| Methylprednisolone Generic | 133 | 133 | 119 | $786 |
Brand drugs: 454 claims; generic drugs: 8,227 claims; opioid claims: 4,989.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kelly E Boussert $1,169 ($1,169 in general payments such as food, travel and fees) from 13 companies. The largest payer was Boston Scientific Corporation with $558.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 15 | $558 |
| Collegium Pharmaceutical, Inc. COLL | 6 | $126 |
| BIOTRONIK NRO, Inc. | 2 | $100 |
| Saluda Medical Americas, Inc. | 1 | $92.5 |
| Abbvie Inc. ABBV | 3 | $50.22 |
| Virtus Pharmaceuticals LLC | 2 | $42.12 |
| Scilex Pharmaceuticals Inc. | 2 | $40.01 |
| Stryker Corporation SYK | 1 | $38.36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $35.67 |
| Abbott Laboratories ABT | 2 | $32.82 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.